Publications
4 shownEnfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who had previousl...
Comprehensive molecular characterization of urothelial bladder carcinoma
Urothelial carcinoma of the bladder is a common malignancy that causes approximately 150,000 deaths per year worldwide. So far, no molecularly targeted agents have been approved...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 13,226
- Institution
- Memorial Sloan Kettering Cancer Center
External Links
Identifiers
- ORCID
- 0000-0003-2637-4249
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.